RTKN2 and osteosarcoma: For example, Wang et al. (Wang X et al. 2018) demonstrated that RTKN2 knockdown promoted G1 phase arrest and apoptosis in human osteosarcoma, implying that RTKN2 acted as an oncogene in human osteosarcoma cell survival.